VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

$29.02
-1.99 (-6.42%)
As of Feb 8, 2:08 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +15.6% upside
Low Target $24.17
Average Target $33.56
High Target $46.23
Current Price $29.02
Current
$29.02
Target
$33.56
$24.17 $33.56 avg $46.23
Scenario Analysis
Bear Case
$24.17
-16.7%
Low target
Base Case
$33.56
+15.6%
Avg target
Bull Case
$46.23
+59.3%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$45.22
-35.8% from high
52-Week Low
$20.51
+41.5% from low
Target vs 52W High
$33.56
-25.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%